{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T14:03:00Z","timestamp":1770818580734,"version":"3.50.1"},"publisher-location":"Chichester, UK","reference-count":92,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd001265.pub2","type":"reference-entry","created":{"date-parts":[[2006,7,18]],"date-time":"2006-07-18T20:38:24Z","timestamp":1153255104000},"source":"Crossref","is-referenced-by-count":46,"title":["Neuraminidase inhibitors for preventing and treating influenza in healthy adults"],"prefix":"10.1002","author":[{"given":"Tom","family":"Jefferson","sequence":"first","affiliation":[]},{"given":"Mark A","family":"Jones","sequence":"additional","affiliation":[]},{"given":"Peter","family":"Doshi","sequence":"additional","affiliation":[]},{"given":"Chris B","family":"Del Mar","sequence":"additional","affiliation":[]},{"given":"Liz","family":"Dooley","sequence":"additional","affiliation":[]},{"given":"Rokuro","family":"Hama","sequence":"additional","affiliation":[]},{"given":"Carl J","family":"Heneghan","sequence":"additional","affiliation":[]}],"member":"311","published-online":{"date-parts":[[2006,7,19]]},"reference":[{"issue":"2","key":"10.1002\/14651858.CD001265.pub2-BIB1|cit1","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2165\/00019053-200017020-00007","article-title":"Impact of zanamivir treatment on productivity, health status and healthcare resource use in patients with influenza","volume":"17","author":"Aoki","year":"2000","journal-title":"Pharmacoeconomics"},{"issue":"4","key":"10.1002\/14651858.CD001265.pub2-BIB2|cit2","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1086\/315392","article-title":"Rapid antiviral effect of inhaled zanamivir in the treatment of naturally occurring influenza in otherwise healthy adults","volume":"181","author":"Boivin","year":"2000","journal-title":"Journal of Infectious Diseases"},{"key":"10.1002\/14651858.CD001265.pub2-BIB3|cit3","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1056\/NEJM199709253371302","article-title":"Efficacy and safety of the neuraminidase inhibitor Zanamivir in the treatment of influenza virus infections","volume":"337","author":"Hayden","year":"1997","journal-title":"New England Journal of Medicine"},{"issue":"18","key":"10.1002\/14651858.CD001265.pub2-BIB4|cit4","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1056\/NEJM199910283411802","article-title":"Use of the selective oral neuraminidase inhibitor oseltamivir to prevent influenza","volume":"341","author":"Hayden","year":"1999","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD001265.pub2-BIB5|cit5","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1056\/NEJM200011023431801","article-title":"Inhaled zanamivir for the prevention of influenza in families","volume":"343","author":"Hayden","year":"2000","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD001265.pub2-BIB6|cit6","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1086\/381128","article-title":"Management of influenza in households: a prospective, randomized comparison of oseltamivir treatment with or without postexposure prophylaxis","volume":"189","author":"Hayden","year":"2004","journal-title":"Journal of Infectious Diseases"},{"issue":"3","key":"10.1002\/14651858.CD001265.pub2-BIB7|cit7","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1086\/313696","article-title":"Short-term treatment with zanamivir to prevent influenza: results of a placebo-controlled study","volume":"30","author":"Kaiser","year":"2000","journal-title":"Clinical Infectious Diseases"},{"issue":"12","key":"10.1002\/14651858.CD001265.pub2-BIB8|cit8","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.11150\/kansenshogakuzasshi1970.74.1062","article-title":"Efficacy and safety of the selective oral neuraminidase inhibitor oseltamivir for prophylaxis against influenza--placebo-controlled double-blind multicenter phase III trial","volume":"74","author":"Kashiwagi","year":"2000","journal-title":"Journal of the Japanese Association for Infectious Diseases"},{"issue":"12","key":"10.1002\/14651858.CD001265.pub2-BIB9|cit9","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.11150\/kansenshogakuzasshi1970.74.1044","article-title":"Clinical efficacy and safety of the selective oral neuraminidase inhibitor oseltamivir in treating acute influenza--placebo-controlled double-blind multicenter phase III trial","volume":"74","author":"Kashiwagi","year":"2000","journal-title":"Journal of the Japanese Association for Infectious Diseases"},{"issue":"1","key":"10.1002\/14651858.CD001265.pub2-BIB10|cit10","first-page":"44","article-title":"A double-blind, randomized, placebo-controlled multicenter study of oseltamivir phosphate for treatment of influenza infection in China","volume":"116","author":"Li","year":"2003","journal-title":"Chinese Medical Journal"},{"issue":"1","key":"10.1002\/14651858.CD001265.pub2-BIB11|cit11","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1053\/jinf.1999.0602","article-title":"Clinical efficacy and safety of the orally inhaled neuraminidase inhibitor zanamivir in the treatment of influenza: a randomized, double-blind, placebo-controlled European study","volume":"40","author":"Makela","year":"2000","journal-title":"Journal of Infection"},{"issue":"2","key":"10.1002\/14651858.CD001265.pub2-BIB12|cit12","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1177\/135965359900400202","article-title":"Safety and efficacy of the neuraminidase inhibitor zanamivir in treating influenza virus infection in adults: results from Japan. GG167 Group","volume":"4","author":"Matsumoto","year":"1999","journal-title":"Antiviral Therapy"},{"key":"10.1002\/14651858.CD001265.pub2-BIB13|cit13","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1016\/S0140-6736(98)10190-3","article-title":"Randomised trial of efficacy and safety of inhaled Zanamivir in treatment of influenza A and B virus infection","volume":"352","year":"1998","journal-title":"Lancet"},{"issue":"1","key":"10.1002\/14651858.CD001265.pub2-BIB14|cit14","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1001\/jama.282.1.31","article-title":"Zanamivir in the prevention of influenza among healthy adults: a randomized controlled trial","volume":"282","author":"Monto","year":"1999","journal-title":"JAMA"},{"issue":"2","key":"10.1002\/14651858.CD001265.pub2-BIB15|cit15","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1086\/314904","article-title":"Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenza A and B virus infections","volume":"180","author":"Monto","year":"1999","journal-title":"Journal of Infectious Diseases"},{"key":"10.1002\/14651858.CD001265.pub2-BIB16|cit16","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1086\/345722","article-title":"Zanamivir prophylaxis: an effective strategy for the prevention of influenza types A and B within households","volume":"186","author":"Monto","year":"2002","journal-title":"Journal of Infectious Diseases"},{"key":"10.1002\/14651858.CD001265.pub2-BIB17|cit17","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1016\/S0140-6736(00)02288-1","article-title":"Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial","volume":"355","author":"Nicholson","year":"2000","journal-title":"Lancet"},{"issue":"1","key":"10.1002\/14651858.CD001265.pub2-BIB18|cit18","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1080\/0036554021000026981","article-title":"Zanamivir: a significant reduction in viral load during treatment in military conscripts with influenza","volume":"35","author":"Puhakka","year":"2003","journal-title":"Scandinavian Journal of Infectious Diseases"},{"issue":"8","key":"10.1002\/14651858.CD001265.pub2-BIB19|cit19","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1001\/jama.283.8.1016","article-title":"Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial","volume":"283","author":"Treanor","year":"2000","journal-title":"JAMA"},{"issue":"6","key":"10.1002\/14651858.CD001265.pub2-BIB20|cit20","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1001\/jama.285.6.748","article-title":"Effectiveness of oseltamivir in preventing influenza in household contacts: a randomized controlled trial","volume":"285","author":"Welliver","year":"2001","journal-title":"JAMA"},{"issue":"6","key":"10.1002\/14651858.CD001265.pub2-BIB21|cit21","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.jamda.2005.08.007","article-title":"Inhaled zanamivir versus placebo for the prevention of influenza outbreaks in an unvaccinated long-term care population","volume":"6","author":"Ambrozaitis","year":"2005","journal-title":"Journal of the American Medical Directors Association"},{"key":"10.1002\/14651858.CD001265.pub2-BIB22|cit22","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/jac\/dkg007","article-title":"Early administration of oral oseltamivir increases the benefits of influenza treatment","volume":"51","author":"Aoki","year":"2003","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"8","key":"10.1002\/14651858.CD001265.pub2-BIB23|cit23","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1177\/135965350501000805","article-title":"Efficacy and tolerability of the oral neuraminidase inhibitor peramivir in experimental human influenza: Randomized, controlled trials for prophylaxis and treatment","volume":"10","author":"Barroso","year":"2005","journal-title":"Antiviral Therapy"},{"issue":"6","key":"10.1002\/14651858.CD001265.pub2-BIB24|cit24","doi-asserted-by":"crossref","first-page":"329","DOI":"10.2165\/00044011-200626060-00004","article-title":"Impact of influenza treatment with oseltamivir on health, sleep and daily activities of otherwise healthy adults and adolescents","volume":"26","author":"Bettis","year":"2006","journal-title":"Clinical Drug Investigation"},{"issue":"4","key":"10.1002\/14651858.CD001265.pub2-BIB25|cit25","first-page":"43","article-title":"Side-effects of oseltamivir (Tamiflu(registered trademark)): BIJWERKINGEN OSELTAMIVIR (TAMIFLU(registered trademark))","volume":"41","author":"Bijl","year":"2007","journal-title":"Geneesmiddelenbulletin"},{"key":"10.1002\/14651858.CD001265.pub2-BIB26|cit26","first-page":"23","article-title":"The safety of oseltamivir in patients with influenza: analysis of healthcare claims data from six influenza seasons","volume":"9","author":"Blumentals","year":"2007","journal-title":"Medscape General Medicine"},{"issue":"7","key":"10.1002\/14651858.CD001265.pub2-BIB27|cit27","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1128\/AAC.43.7.1616","article-title":"Safety and efficacy of intravenous zanamivir in preventing experimental human influenza A virus infection","volume":"43","author":"Calfee","year":"1999","journal-title":"Antimicrobial Agents & Chemotherapy"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD001265.pub2-BIB28|cit28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00003088-199936001-00001","article-title":"Pharmacokinetics of zanamivir after intravenous, oral, inhaled or intranasal administration to healthy volunteers","volume":"36","author":"Cass","year":"1999","journal-title":"Clinical Pharmacokinetics"},{"issue":"7134","key":"10.1002\/14651858.CD001265.pub2-BIB29|cit29","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/446358a","article-title":"Tamiflu side effects come under scrutiny","volume":"446","author":"Fuyuno","year":"2007","journal-title":"Nature"},{"issue":"1-2","key":"10.1002\/14651858.CD001265.pub2-BIB30|cit30","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3233\/JRS-2008-0431","article-title":"Fatal neuropsychiatric adverse reactions to oseltamivir: Case series and overview of causal relationships","volume":"20","author":"Hama","year":"2008","journal-title":"International Journal of Risk and Safety in Medicine"},{"issue":"13","key":"10.1002\/14651858.CD001265.pub2-BIB31|cit31","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1001\/jama.282.13.1240","article-title":"Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for prevention and treatment","volume":"282","author":"Hayden","year":"1999","journal-title":"JAMA"},{"issue":"3","key":"10.1002\/14651858.CD001265.pub2-BIB32|cit32","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1177\/135965350000500305","article-title":"Oral oseltamivir in human experimental influenza B infection","volume":"5","author":"Hayden","year":"2000","journal-title":"Antiviral Therapy"},{"key":"10.1002\/14651858.CD001265.pub2-BIB33|cit33","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1177\/135965350300800301","article-title":"Safety and efficacy of nebulised zanamivir in hospitalised patients with serious influenza","volume":"8","author":"Ison","year":"2003","journal-title":"Antiviral Therapy"},{"key":"10.1002\/14651858.CD001265.pub2-BIB34|cit34","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1001\/archinte.163.14.1667","article-title":"Impact of oseltamivir treatment on influenza related lower respiratory tract infections","volume":"163","author":"Kaiser","year":"2003","journal-title":"Archives of Internal Medicine"},{"issue":"9","key":"10.1002\/14651858.CD001265.pub2-BIB35|cit35","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1086\/429241","article-title":"Factors influencing the effectiveness of oseltamivir and amantadine for the treatment of influenza: a multicenter study from Japan of the 2002-2003 influenza season","volume":"40","author":"Kawai","year":"2005","journal-title":"Clinical Infectious Diseases"},{"issue":"4","key":"10.1002\/14651858.CD001265.pub2-BIB36|cit36","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1086\/505868","article-title":"A comparison of the effectiveness of oseltamivir for the treatment of influenza A and influenza B: a Japanese multicenter study of the 2003-2004 and 2004-2005 influenza seasons","volume":"43","author":"Kawai","year":"2006","journal-title":"Clinical Infectious Diseases"},{"issue":"12","key":"10.1002\/14651858.CD001265.pub2-BIB37|cit37","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1086\/518385","article-title":"Zanamivir treatment is equally effective for both influenza A and influenza B","volume":"44","author":"Kawai","year":"2007","journal-title":"Clinical Infectious Diseases"},{"issue":"5","key":"10.1002\/14651858.CD001265.pub2-BIB38|cit38","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1007\/s10156-007-0538-3","article-title":"A change in the effectiveness of amantadine for the treatment of influenza over the 2003-2004, 2004-2005, and 2005-2006 influenza seasons in Japan","volume":"13","author":"Kawai","year":"2007","journal-title":"Journal of Infection and Chemotherapy"},{"issue":"3","key":"10.1002\/14651858.CD001265.pub2-BIB39|cit39","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jinf.2007.05.176","article-title":"Longer virus shedding in influenza B than in influenza A among outpatients treated with oseltamivir","volume":"55","author":"Kawai","year":"2007","journal-title":"The Journal of Infection"},{"issue":"1","key":"10.1002\/14651858.CD001265.pub2-BIB40|cit40","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jinf.2007.09.002","article-title":"A comparison of the effectiveness of zanamivir and oseltamivir for the treatment of influenza A and B","volume":"56","author":"Kawai","year":"2008","journal-title":"The Journal of Infection"},{"issue":"8","key":"10.1002\/14651858.CD001265.pub2-BIB41|cit41","doi-asserted-by":"crossref","first-page":"1579-90; discus","DOI":"10.1016\/j.clinthera.2007.08.023","article-title":"Efficacy and safety of inhaled zanamivir in the prevention of influenza in community-dwelling, high-risk adult and adolescent subjects: a 28-day, multicenter, randomized, double-blind, placebo-controlled trial","volume":"29","author":"LaForce","year":"2007","journal-title":"Clinical Therapeutics"},{"issue":"12","key":"10.1002\/14651858.CD001265.pub2-BIB42|cit42","first-page":"838","article-title":"A multicenter study of efficacy and safety of oseltamivir in treatment of naturally acquired influenza","volume":"40","author":"Li","year":"2001","journal-title":"Chinese Journal of Internal Medicine"},{"issue":"1","key":"10.1002\/14651858.CD001265.pub2-BIB43|cit43","first-page":"44","article-title":"A double-blind, randomized, placebo-controlled multicenter study of oseltamivir phosphate for treatment of influenza infection in China","volume":"116","author":"Li","year":"2004","journal-title":"Chinese Medical Journal"},{"issue":"1","key":"10.1002\/14651858.CD001265.pub2-BIB44|cit44","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1185\/030079906X80297","article-title":"A multicentre, randomized, controlled trial of oseltamivir in the treatment of influenza in a high-risk Chinese population","volume":"22","author":"Lin","journal-title":"Current Medical Research and Opinion"},{"issue":"7523","key":"10.1002\/14651858.CD001265.pub2-BIB45|cit45","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1136\/bmj.38649.389005.DE","article-title":"Bird flu and pandemic flu","volume":"331","author":"Macfarlane","year":"2005","journal-title":"BMJ"},{"issue":"8","key":"10.1002\/14651858.CD001265.pub2-BIB46|cit46","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1177\/00912700022009567","article-title":"The pharmacokinetics and tolerability of the oral neuraminidase inhibitor oseltamivir (Ro 64-0796\/GS4104) in healthy adult and elderly volunteers","volume":"40","author":"Massarella","year":"2000","journal-title":"Journal of Clinical Pharmacology"},{"issue":"Suppl B","key":"10.1002\/14651858.CD001265.pub2-BIB47|cit47","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/jac\/44.suppl_2.23","article-title":"Randomized, placebo-controlled studies of inhaled zanamivir in the treatment of influenza A and B: pooled efficacy analysis","volume":"44","author":"Monto","year":"1999","journal-title":"Journal of Antimicrobial Chemotherapy"},{"issue":"5","key":"10.1002\/14651858.CD001265.pub2-BIB48|cit48","doi-asserted-by":"crossref","first-page":"337","DOI":"10.2165\/00044011-200020050-00005","article-title":"Efficacy and safety of inhaled zanamivir for the treatment of influenza in patients with asthma or chronic obstructive pulmonary disease: A double-blind, randomised, placebo-controlled, multicentre","volume":"20","author":"Murphy","year":"2000","journal-title":"Clinical Drug Investigation"},{"issue":"7","key":"10.1002\/14651858.CD001265.pub2-BIB49|cit49","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1128\/AAC.44.7.1974-1976.2000","article-title":"Direct measurement of the anti-influenza agent zanamivir in the respiratory tract following inhalation","volume":"44","author":"Peng","year":"2000","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"10","key":"10.1002\/14651858.CD001265.pub2-BIB50|cit50","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1097\/01.inf.0000180976.81055.ce","article-title":"Viral shedding in children with influenza virus infections treated with neuraminidase inhibitors","volume":"24","author":"Sato","year":"2005","journal-title":"The Pediatric Infectious Disease Journal"},{"issue":"2","key":"10.1002\/14651858.CD001265.pub2-BIB51|cit51","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1620\/tjem.214.113","article-title":"Effectiveness of oseltamivir treatment among children with influenza A or B virus infections during four successive winters in Niigata City, Japan","volume":"214","author":"Sato","year":"2008","journal-title":"The Tohoku Journal of Experimental Medicine"},{"key":"10.1002\/14651858.CD001265.pub2-BIB52|cit52","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.2165\/0002018-200831120-00006","article-title":"Assessment of neuropsychiatric adverse events in influenza patients treated with oseltamivir: a comprehensive review","volume":"31","author":"Toovey","year":"2008","journal-title":"Drug Safety"},{"key":"10.1002\/14651858.CD001265.pub2-BIB53|cit53","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S1473-3099(09)70199-9","article-title":"Prescription of anti-influenza drugs for healthy adults: a systematic review and meta-analysis","volume":"9","author":"Burch","year":"2009","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD001265.pub2-BIB54|cit54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta6090","article-title":"Zanamivir for the treatment of influenza in adults: a systematic review and economic evaluation","volume":"6","author":"Burls","year":"2002","journal-title":"Health Technology Assessment"},{"key":"10.1002\/14651858.CD001265.pub2-BIB55|cit55","unstructured":"Burns WM Tamiflu media briefing www.roche.com\/mb_090907.pdf (Accessed 30 October 2009) 2009"},{"key":"10.1002\/14651858.CD001265.pub2-BIB56|cit56","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1136\/bmj.326.7401.1235","article-title":"Effectiveness of neuraminidase inhibitors in treatment and prevention of influenza A and B: systematic review and meta-analysis of randomised controlled trials","volume":"326","author":"Cooper","year":"2003","journal-title":"BMJ"},{"issue":"25","key":"10.1002\/14651858.CD001265.pub2-BIB57|cit57","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1056\/NEJMoa054512","article-title":"Oseltamivir resistance during treatment of influenza A (H5N1) infection","volume":"353","author":"Jong","year":"2005","journal-title":"NEJM"},{"key":"10.1002\/14651858.CD001265.pub2-BIB58|cit58","unstructured":"Doerler BR Roche Antiviral Program Protection for Corporporate Stockpiling http:\/\/events.sifma.org\/uploadedFiles\/Events\/2008\/BCP\/Brooke%20Doerler%20presentation.pdf (accessed 13 October 2009) 2009 10"},{"key":"10.1002\/14651858.CD001265.pub2-BIB59|cit59","doi-asserted-by":"crossref","first-page":"b5164","DOI":"10.1136\/bmj.b5164","article-title":"The story behind the review","volume":"339","author":"Doshi","year":"2009","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD001265.pub2-BIB60|cit60","unstructured":"European Center for Disease Prevention and Control Influenza Tables: Antiviral resistance - Archive weekly updates (week 21\/2009) www.ecdc.europa.eu\/en\/healthtopics\/Lists\/Influenza%20tables\/DispForm.aspx?ID=1&RootFolder=%2Fen%2Fhealthtopics%2FLists%2FInfluenza%20tables (Accessed 13 October 2009) 2009"},{"key":"10.1002\/14651858.CD001265.pub2-BIB61|cit61","volume-title":"Summary Report. Review on influenza antiviral medicinal products for potential use during pandemic","year":"2005"},{"key":"10.1002\/14651858.CD001265.pub2-BIB62|cit62","unstructured":"European Medicines Agency Tamiflu. Annex 1: Summary of product characteristics www.emea.europa.eu\/humandocs\/PDFs\/EPAR\/tamiflu\/emea-combined-h402en.pdf (Accessed 31 October 2009) 2009 10"},{"key":"10.1002\/14651858.CD001265.pub2-BIB63|cit63","unstructured":"Food Drug Administration US Food and Drug Administration (FDA). CFR - Code of Federal Regulations Title 21. Sec. 314.80 Postmarketing reporting of adverse drug experiences www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfcfr\/CFRSearch.cfm?fr=314.80 (accessed 30 Oct 09) 2009"},{"key":"10.1002\/14651858.CD001265.pub2-BIB64|cit64","unstructured":"Food Drug Administration Food and Drug Administration: Adverse events reporting system http:\/\/www.fda.gov\/Drugs\/GuidanceComplianceRegulatoryInformation\/Surveillance\/AdverseDrugEffects\/default.htm (Accessed 13 Oct 2009) 2009"},{"key":"10.1002\/14651858.CD001265.pub2-BIB65|cit65","unstructured":"US Food Drug Administration The adverse event reporting system (AERS): older quarterly data files www.fda.gov\/Drugs\/GuidanceComplianceRegulatoryInformation\/Surveillance\/AdverseDrugEffects\/ucm083765.htm 2009"},{"key":"10.1002\/14651858.CD001265.pub2-BIB66|cit66","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1378\/chest.06-1997","article-title":"Influenza and COPD mortality protection as pleiotropic, dose-dependent effects of statins","volume":"131","author":"Frost","year":"2007","journal-title":"Chest"},{"issue":"1","key":"10.1002\/14651858.CD001265.pub2-BIB67|cit67","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1471-1842.2006.00634.x","article-title":"Developing efficient search strategies to identify reports of adverse effects in MEDLINE and EMBASE","volume":"23","author":"Golder","year":"2006","journal-title":"Health Info Libr J"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD001265.pub2-BIB68|cit68","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1086\/591851","article-title":"Developing new antiviral agents for influenza treatment: what does the future hold?","volume":"48","author":"Hayden","year":"2009","journal-title":"Clinical Infectious Diseases"},{"key":"10.1002\/14651858.CD001265.pub2-BIB69|cit69","article-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 [updated September 2008]","volume-title":"The Cochrane Collaboration, 2008. Available from www.cochrane-handbook.org.","author":"Higgins","year":"2008"},{"key":"10.1002\/14651858.CD001265.pub2-BIB70|cit70","doi-asserted-by":"crossref","DOI":"10.1002\/9780470712184.ch8","article-title":"Chapter 8:\u00a0 Assessing risk of bias in included studies","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 (Available from www.cochrane-handbook.org)","author":"Higgins","year":"2008"},{"key":"10.1002\/14651858.CD001265.pub2-BIB71|cit71","volume-title":"Comprehending behavioral statistics","author":"Hurlburt","year":"1994"},{"key":"10.1002\/14651858.CD001265.pub2-BIB72|cit72","unstructured":"Jefferson TO Guest Editorial. Mistaken identity: seasonal influenza versus influenza-like illness Clinical Evidence (http:\/\/clinicalevidence.bmj.com\/downloads\/05-10-09.pdf) (Accessed 2 November 2009) 2009"},{"key":"10.1002\/14651858.CD001265.pub2-BIB73|cit73","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/S0140-6736(09)61804-3","article-title":"Possible harms of oseltamivir--a call for urgent action","volume":"374","author":"Jefferson","year":"2009","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD001265.pub2-BIB74|cit74","doi-asserted-by":"crossref","first-page":"b3675","DOI":"10.1136\/bmj.b3675","article-title":"Physical interventions to interrupt or reduce the spread of respiratory viruses: systematic review","volume":"339","author":"Jefferson","year":"2009","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD001265.pub2-BIB75|cit75","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0140-6736(04)16934-1","article-title":"Resistant influenza A viruses in children treated with oseltamivir: descriptive study","volume":"364","author":"Kiso","year":"2004","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD001265.pub2-BIB76|cit76","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0140-6736(04)15589-X","article-title":"Transmission of H7N7 avian influenza A virus to human beings during a large outbreak in commercial poultry farms in the Netherlands","volume":"363","author":"Koopmans","year":"2004","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD001265.pub2-BIB77|cit77","first-page":"5","article-title":"Emergence of resistance to oseltamivir among influenza A(H1N1) viruses in Europe","volume":"13","author":"Lackenby","year":"2008","journal-title":"Euro Surveillance"},{"key":"10.1002\/14651858.CD001265.pub2-BIB78|cit78","article-title":"Highly sensitive search strategies for identifying reports of randomized controlled trials in MEDLINE : sensitivity-maximizing version (2008 revision)","volume-title":"Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions. Chapter 6: Searching for studies","author":"Lefebvre","year":"2008"},{"key":"10.1002\/14651858.CD001265.pub2-BIB79|cit79","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1002\/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8","article-title":"Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints","volume":"17","author":"Parmar","year":"1998","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD001265.pub2-BIB80|cit80","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1016\/S0140-6736(06)68683-2","article-title":"Antivirals for influenza in healthy adults","volume":"367","author":"Smith","year":"2006","journal-title":"Lancet"},{"issue":"iii, ix-xii","key":"10.1002\/14651858.CD001265.pub2-BIB81|cit81","first-page":"1","article-title":"Amantadine, oseltamivir and zanamivir for the prophylaxis of influenza (including a review of existing guidance no. 67): a systematic review and economic evaluation","volume":"13","author":"Tappenden","year":"2009","journal-title":"Health Technology Assessment"},{"issue":"iii-iv, xi-xiii","key":"10.1002\/14651858.CD001265.pub2-BIB82|cit82","first-page":"1","article-title":"Systematic review and economic decision modelling for the prevention and treatment of influenza A and B","volume":"7","author":"Turner","year":"2003","journal-title":"Health Technology Assessment"},{"key":"10.1002\/14651858.CD001265.pub2-BIB83|cit83","doi-asserted-by":"crossref","unstructured":"Tweed SA Skowronski DM David ST Larder A Petric M Lees M Human illness from avian influenza H7N3, British Columbia Emerging Infectious Diseases (Available from http:\/\/www.cdc.gov\/ncidod\/EID\/vol10no12\/04-0961.htm (accessed 3 November 2005)) 2004","DOI":"10.3201\/eid1012.040961"},{"key":"10.1002\/14651858.CD001265.pub2-BIB84|cit84","first-page":"i15","article-title":"Oseltamivir (Tamiflu) and its potential for use in the event of an influenza pandemic","volume-title":"Journal of antimicrobial chemotherapy","volume":"55","author":"Ward","year":"2005"},{"key":"10.1002\/14651858.CD001265.pub2-BIB85|cit85","unstructured":"World Health Organisation Global Agenda on Influenza Surveillance and Control http:\/\/www.who.int\/csr\/disease\/influenza\/csrinfluenzaglobalagenda\/en\/print.html (accessed 10 october 2005)"},{"key":"10.1002\/14651858.CD001265.pub2-BIB86|cit86","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1056\/NEJMra052211","article-title":"Avian Influenza A (H5N1) Infection in Humans","volume":"353","year":"2005","journal-title":"NEJM"},{"issue":"3","key":"10.1002\/14651858.CD001265.pub2-BIB87|cit87","first-page":"189","article-title":"Human infection by avian influenza A H5N1","volume":"11","author":"Yuen","year":"2005","journal-title":"Hong Kong Medical Journal"},{"issue":"2","key":"10.1002\/14651858.CD001265.pub2-BIB88|cit88","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001265","article-title":"Neuraminidase inhibitors in the prophylaxis and treatment of influenza in healthy adults","author":"Jefferson","year":"1999","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD001265.pub2-BIB89|cit89","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0264-410X(99)00332-1","article-title":"Prevention and early treatment of influenza in healthy adults","volume":"18","author":"Jefferson","year":"2000","journal-title":"Vaccine"},{"issue":"3","key":"10.1002\/14651858.CD001265.pub2-BIB90|cit90","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001265.pub2","article-title":"Neuraminidase inhibitors for preventing and treating influenza in healthy adults","author":"Jefferson","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD001265.pub2-BIB91|cit91","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002190.pub2","article-title":"Neuraminidase inhibitors for preventing and treating influenza in healthy adults","author":"Jefferson","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"339","key":"10.1002\/14651858.CD001265.pub2-BIB92|cit92","doi-asserted-by":"crossref","first-page":"b5106","DOI":"10.1136\/bmj.b5106","article-title":"Neuraminidase inhibitors for preventing and treating influenza in healthy adults: systematic review and meta-analysis","author":"Jefferson","year":"2009","journal-title":"BMJ"}],"updated-by":[{"DOI":"10.1002\/14651858.cd001265.pub3","type":"withdrawal","label":"Withdrawal","source":"publisher","updated":{"date-parts":[[2011,3,16]],"date-time":"2011-03-16T00:00:00Z","timestamp":1300233600000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD001265.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,8]],"date-time":"2023-05-08T04:08:41Z","timestamp":1683518921000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD001265.pub2"}},"subtitle":[],"editor":[{"given":"Tom","family":"Jefferson","sequence":"additional","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2006,7,19]]},"references-count":92,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd001265.pub2","relation":{"withdrawal":[{"id-type":"doi","id":"10.1002\/14651858.CD001265.pub3","asserted-by":"object"}]},"subject":[],"published":{"date-parts":[[2006,7,19]]}}}